Clair Health's continuous hormone monitoring device uses multiple physiological signals to non-invasively track estrogen, progesterone, LH, and FSH in real time, addressing a critical gap in wearable data interpretation for women. The approach shifts focus from isolated readings to hormonal patterns over time, providing earlier insight into physiological changes that existing devices capture but cannot contextualize.
Key Points
- Wrist-worn device infers four key hormones continuously without blood draws
- Beta testing identified nine hormonal sub-phases versus traditional four-phase model
- Continuous endocrine data contextualizes existing signals from other wearables
Longevity Analysis
The ability to decode hormonal patterns continuously addresses a fundamental blind spot in health monitoring. Hormones regulate sleep, cognition, metabolism, recovery and cardiovascular function — systems that existing wearables measure without understanding their endocrine drivers. For women navigating perimenopause, this represents the difference between reactive symptom management and prospective physiological understanding. The validation of nine distinct hormonal phases rather than four suggests existing clinical frameworks may misrepresent female physiology, potentially explaining why interventions lack precision. Continuous endocrine intelligence becomes actionable only when it informs earlier detection of metabolic shifts, cardiovascular risk changes, or regenerative capacity decline — making signal interpretation the actual therapeutic advantage.
Original published by Longevity.Technology, by Eleanor Garth.